Laboratorios Farmaceuticos Rovi, S.A. Stock
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.20 EUR | +2.74% |
|
+4.46% | -11.50% |
| May. 13 | Spanish stocks - Factors to watch on May 13 | RE |
| May. 09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 2.87B 3.28B 2.67B 2.45B 4.62B 317B 4.69B 31.79B 12.44B 155B 12.32B 12.05B 535B | P/E 2026 * |
21.7x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.86B 3.26B 2.65B 2.44B 4.59B 315B 4.66B 31.6B 12.37B 154B 12.24B 11.98B 532B | EV / Sales 2026 * |
3.71x | EV / Sales 2027 * | 3.13x |
| Free-Float |
31.63% | Yield 2026 * |
1.73% | Yield 2027 * | 1.99% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| Feb. 25 | Spanish stocks - Factors to watch on Feb 25 | RE |
| Nov. 06 | Spanish stocks - Factors to watch on Nov 6 | RE |
| 25-03-05 | Spanish stocks - Factors to watch on March 5 | RE |
| 1 day | +2.74% | ||
| 1 week | +4.46% | ||
| Current month | -2.85% | ||
| 1 month | -4.26% | ||
| 3 months | -34.15% | ||
| 6 months | -23.64% | ||
| Current year | -11.50% |
| 1 week | 53.3 |  | 57.65 |
| 1 month | 53.1 | | 59.65 |
| Current year | 53.1 | | 86.7 |
| 1 year | 51.65 | | 86.7 |
| 3 years | 41.14 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2007-07-26 | |
| Director of Finance/CFO | - | 2000-12-31 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-16 | |
| Director/Board Member | - | 2007-07-26 | |
| Director/Board Member | - | 2007-07-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/23/23 | Buy | Director | 1,000 | 0.0019% | ||
| 4/13/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 3/15/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.74% | +4.46% | +6.24% | +33.81% | 3.19B | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,048B | |
| +2.00% | +3.49% | +52.22% | +50.20% | 603B | |
| -1.09% | +3.76% | +35.37% | +76.22% | 452B | |
| -0.42% | +0.67% | +30.81% | +21.05% | 327B | |
| -0.16% | +2.74% | +36.02% | +37.33% | 283B | |
| +1.68% | +1.08% | +22.70% | +17.94% | 259B | |
| -1.40% | -3.34% | -24.63% | -42.39% | 219B | |
| -0.05% | +2.16% | +19.75% | +55.89% | 198B | |
| +0.05% | -1.03% | +18.31% | +61.63% | 162B | |
| Average | +0.02% | +2.05% | +24.66% | +46.34% | 355.49B | |
| Weighted average by Cap. | -0.47% | +1.87% | +35.83% | +72.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 770M 879M 715M 657M 1.24B 84.82B 1.26B 8.52B 3.33B 41.5B 3.3B 3.23B 143B | 890M 1.02B 826M 759M 1.43B 98.04B 1.45B 9.85B 3.85B 47.97B 3.81B 3.73B 166B |
| Net income | 131M 150M 122M 112M 211M 14.46B 214M 1.45B 568M 7.07B 562M 550M 24.44B | 174M 199M 162M 149M 280M 19.18B 284M 1.93B 754M 9.38B 746M 730M 32.41B |
| Net Debt | -16.89M -19.28M -15.68M -14.41M -27.15M -1.86B -27.55M -187M -73.11M -910M -72.36M -70.8M -3.14B | -84.75M -96.73M -78.68M -72.3M -136M -9.33B -138M -937M -367M -4.57B -363M -355M -15.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | €56.20 | +2.74% | 314,953 |
| 26-07-21 | €54.70 | +1.20% | 136,739 |
| 26-07-20 | €54.05 | -0.18% | 92,548 |
| 26-07-17 | €54.15 | +0.84% | 79,556 |
| 26-07-16 | €53.70 | -0.19% | 83,894 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
